JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs
JenaValve Technology has appointed Tonya Porter as Vice President of Regulatory Affairs, succeeding Jane Metcalf. With over 20 years of experience in clinical, regulatory, and quality affairs in medical devices, Porter will lead regulatory efforts as JenaValve progresses its Trilogy Transcatheter Heart Valve System. The Trilogy THV System is designed for patients with severe aortic regurgitation and has received CE Mark approval in Europe.
IRVINE, Calif., May 20, 2026 (GLOBE NEWSWIRE) — JenaValve Technology, Inc., developer and manufacturer of the Trilogy® Transcatheter Heart Valve (THV) System, today announced the appointment of Tonya Porter as Vice President of Regulatory Affairs. Tonya will lead the company’s regulatory affairs function as JenaValve advances its programs through clinical development and ongoing commercialization efforts. She succeeds Jane Metcalf, who is retiring following a distinguished tenure at JenaValve.